CMR FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindahl, G.
Right arrow Articles by Areschoug, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindahl, G.
Right arrow Articles by Areschoug, T.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, January 2005, p. 102-127, Vol. 18, No. 1
0893-8512/05/$08.00+0     doi:10.1128/CMR.18.1.102-127.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens

Gunnar Lindahl,* Margaretha Stålhammar-Carlemalm, and Thomas Areschoug

Department of Medical Microbiology, Dermatology and Infection, Lund University, Sölvegatan 23, Lund, Sweden

Streptococcus agalactiae (group B Streptococcus) is the major cause of invasive bacterial disease, including meningitis, in the neonatal period. Although prophylactic measures have contributed to a substantial reduction in the number of infections, development of a vaccine remains an important goal. While much work in this field has focused on the S. agalactiae polysaccharide capsule, which is an important virulence factor that elicits protective immunity, surface proteins have received increasing attention as potential virulence factors and vaccine components. Here, we summarize current knowledge about S. agalactiae surface proteins, with emphasis on proteins that have been characterized immunochemically and/or elicit protective immunity in animal models. These surface proteins have been implicated in interactions with human epithelial cells, binding to extracellular matrix components, and/or evasion of host immunity. Of note, several S. agalactiae surface proteins are related to surface proteins identified in other bacterial pathogens, emphasizing the general interest of the S. agalactiae proteins. Because some S. agalactiae surface proteins elicit protective immunity, they hold promise as components in a vaccine based only on proteins or as carriers in polysaccharide conjugate vaccines.


* Corresponding author. Mailing address: Department of Medical Microbiology, Dermatology and Infection, Lund University, Sölvegatan 23, SE-22362 Lund, Sweden. Phone: 46 (46) 173244. Fax: 46 (46) 189117. E-mail: gunnar.lindahl{at}mmb.lu.se.


Clinical Microbiology Reviews, January 2005, p. 102-127, Vol. 18, No. 1
0893-8512/05/$08.00+0     doi:10.1128/CMR.18.1.102-127.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Vaccine Immunol.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.